Benzimidazole-2-one: A novel anchoring principle for antagonizing p53-Mdm2
Authors:
- 1 July 2013
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 21 (14) , 3982-3995
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Rational Approaches to Improving Selectivity in Drug DesignJournal of Medicinal Chemistry, 2012
- The Structure‐Based Design of Mdm2/Mdmx–p53 Inhibitors Gets SeriousAngewandte Chemie International Edition, 2011
- Systematic Analysis of Helical Protein Interfaces Reveals Targets for Synthetic InhibitorsACS Chemical Biology, 2010
- ANCHOR: a web server and database for analysis of protein-protein interaction binding pockets for drug discoveryNucleic Acids Research, 2010
- A Medicinal Chemist’s Guide to Molecular InteractionsJournal of Medicinal Chemistry, 2010
- Targeting the cancer kinome through polypharmacologyNature Reviews Cancer, 2010
- Rapid and Efficient Hydrophilicity Tuning of p53/mdm2 AntagonistsJournal of Combinatorial Chemistry, 2009
- Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 InteractionJournal of Medicinal Chemistry, 2006
- Protein–protein interactions as targets for small molecule drug discoveryPeptide Science, 2006
- Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in CellsJournal of Medicinal Chemistry, 2005